» Articles » PMID: 38362034

Evolutionary Conservation of Putative Suicidality-related Risk Genes That Produce Diminished Motivation Corrected by Clozapine, Lithium and Antidepressants

Overview
Specialty Psychiatry
Date 2024 Feb 16
PMID 38362034
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Genome wide association studies (GWAS) and candidate gene analyses have identified genetic variants and genes that may increase the risk for suicidal thoughts and behaviors (STBs). Important unresolved issues surround these tentative risk variants such as the characteristics of the associated genes and how they might elicit STBs.

Methods: Putative suicidality-related risk genes (PSRGs) were identified by comprehensive literature search and were characterized with respect to evolutionary conservation, participation in gene interaction networks and associated phenotypes. Evolutionary conservation was established with database searches and BLASTP queries, whereas gene-gene interactions were ascertained with GeneMANIA. We then examined whether mutations in risk-gene counterparts in produced a diminished motivation phenotype previously connected to suicide risk factors.

Results And Conclusions: From the analysis, 105 risk-gene candidates were identified and found to be: 1) highly conserved during evolution, 2) enriched for essential genes, 3) involved in significant gene-gene interactions, and 4) associated with psychiatric disorders, metabolic disturbances and asthma/allergy. Evaluation of 17 mutant strains with loss-of-function/deletion mutations in PSRG orthologs revealed that 11 mutants showed significant evidence of diminished motivation that manifested as immobility in a foraging assay. Immobility was corrected in some or all of the mutants with clozapine, lithium and tricyclic antidepressant drugs. In addition, 5-HT2 receptor and muscarinic receptor antagonists restored goal-directed behavior in most or all of the mutants. These studies increase confidence in the validity of the PSRGs and provide initial clues about possible mechanisms that mediate STBs.

Citing Articles

Converging evidence for functional connections between the lithium response and PI3K-Akt signaling.

Dwyer D Transl Psychiatry. 2024; 14(1):458.

PMID: 39487122 PMC: 11530542. DOI: 10.1038/s41398-024-03160-y.

References
1.
Jimenez E, Arias B, Mitjans M, Goikolea J, Roda E, Saiz P . Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients. Eur Neuropsychopharmacol. 2013; 23(11):1452-62. DOI: 10.1016/j.euroneuro.2013.01.007. View

2.
Dagenhardt J, Trinh A, Sumner H, Scott J, Aamodt E, Dwyer D . Insulin Signaling Deficiency Produces Immobility in That Models Diminished Motivation States in Man and Responds to Antidepressants. Mol Neuropsychiatry. 2017; 3(2):97-107. PMC: 5701274. DOI: 10.1159/000478049. View

3.
Kuhn R . The treatment of depressive states with G 22355 (imipramine hydrochloride). Am J Psychiatry. 1958; 115(5):459-64. DOI: 10.1176/ajp.115.5.459. View

4.
Saul J, Hirose T, Horvitz H . The transcriptional corepressor CTBP-1 acts with the SOX family transcription factor EGL-13 to maintain AIA interneuron cell identity in . Elife. 2022; 11. PMC: 8816384. DOI: 10.7554/eLife.74557. View

5.
Wohleb E, Wu M, Gerhard D, Taylor S, Picciotto M, Alreja M . GABA interneurons mediate the rapid antidepressant-like effects of scopolamine. J Clin Invest. 2016; 126(7):2482-94. PMC: 4922686. DOI: 10.1172/JCI85033. View